Published date: 11 January 2023
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Research services - 73110000
Location of contract
England
Value of contract
£388,000
Procurement reference
NCL001-DN649127-22255881
Published date
11 January 2023
Closing date
13 February 2023
Closing time
12pm
Contract start date
20 February 2023
Contract end date
30 March 2028
Contract type
Service contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including the "NASH Disease Translational Accelerator" (NASH-DTA) project. This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD). Their common goals are developing, validating and qualifying better biomarkers for NAFLD. Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression. Biomarkers under investigation in the project include genes that contribute to NAFLD progression. The NASH-DTA project has two parts: retrospective and prospective study. Retrospective study is based on analysing existing samples, prospective study will recruit 200 patients and collect new samples over 5 years.
The purpose of this tender process is to engage a supplier to provide metabolomic analysis on plasma samples from both a retrospective and prospective study using AbsolutelDQ Bile Acids kit and MxP Quant 500 Kit.
About the buyer
Contact name
Emma Barksby
Address
Newcastle University
Procurement Services, Kingsgate
Newcastle
NE1 7RU
England
Telephone
+44 1912086298
Website
Share this notice
Closing: 13 February 2023, 12pm
All content is available under the
